AnaptysBioANAB
那斯達克 · USD
60.31
+1.57
(+2.67%)
盤中 05/20 01:52 (UTC+8)
05/20 01:52 (UTC+8)
AnaptysBioANAB
60.31
+1.57
(+2.67%)
財務數據
損益表
- 0.09
- 0.07
- 0.11
- 0.30
- 0.43
- 0.28
- 0.22
- 0.76
- 1.08
- 0.26
- 171.40
- -20.28
- 52.82
- 173.60
- 43.63
- -35.59
- -19.83
- 242.81
- 41.84
- -76.39
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 25,556 | 108,249 | 76,320 | 22,263 | 27,771 | 43,113 | 30,017 | 10,971 | 7,179 | 9,005 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 25,556 | 108,249 | 76,320 | 22,263 | 27,771 | 43,113 | 30,017 | 10,971 | 7,179 | 9,005 |
營業費用 | 60,193 | 41,348 | 41,616 | 48,433 | 55,310 | - | 52,774 | - | - | 51,140 |
研發費用 | 33,991 | 25,559 | 31,407 | 37,824 | 41,180 | 42,589 | 42,212 | 41,997 | 37,042 | 33,525 |
推銷及管理費用 | 26,202 | 15,789 | 10,209 | 10,609 | 14,130 | 10,194 | 10,562 | 9,295 | 12,338 | 10,276 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | 7,339 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -34,637 | 66,901 | 34,704 | -26,170 | -27,539 | -9,670 | -22,757 | -40,321 | -42,201 | -42,135 |
其他收入及費用 | 2,652 | 2,505 | 2,924 | 7,185 | 6,315 | 5,284 | 5,319 | 4,623 | 4,582 | 4,878 |
利息費用 | 20,859 | 19,711 | 22,515 | 19,606 | 18,061 | 17,404 | 15,413 | 10,953 | 6,317 | 4,958 |
稅前純益 | -52,844 | 49,695 | 15,113 | -38,591 | -39,285 | -21,790 | -32,851 | -46,651 | -43,936 | -42,215 |
所得稅 | 40 | 81 | - | 39 | 44 | -6 | - | 9 | - | -4 |
稅後純益 | -52,884 | 49,614 | 15,113 | -38,630 | -39,329 | -21,784 | -32,851 | -46,660 | -43,936 | -42,211 |
基本每股稅後盈餘(元) | -1.84 | 1.79 | 0.54 | -1.34 | -1.28 | -0.72 | -1.14 | -1.71 | -1.64 | - |
稀釋每股稅後盈餘(元) | -1.84 | 1.70 | 0.46 | -1.34 | -1.28 | -0.66 | -1.11 | -1.71 | -1.64 | -1.59 |
基本平均股數(千股) | 28691.00 | 27789.00 | 27833.00 | 28810.00 | 30644.00 | 30448.00 | 28893.00 | 27356.00 | 26801.00 | - |
稀釋平均股數(千股) | 28691.00 | 31343.00 | 29018.00 | 28810.00 | 30644.00 | 30448.00 | 28893.00 | 27356.00 | 26801.00 | - |
還原基本每股稅後盈餘(元) | -1.84 | 1.79 | 0.54 | -1.34 | -1.28 | -0.72 | -1.14 | -1.71 | -1.64 | - |
還原稀釋每股稅後盈餘(元) | -1.84 | 1.70 | 0.46 | -1.34 | -1.28 | -0.66 | -1.11 | -1.71 | -1.64 | -1.59 |
還原基本平均股數(千股) | 28,691 | 27,789 | 27,833 | 28,810 | 30,644 | 30,448 | 28,893 | 27,356 | 26,801 | - |
還原稀釋平均股數(千股) | 28,691 | 31,343 | 29,018 | 28,810 | 30,644 | 30,448 | 28,893 | 27,356 | 26,801 | - |
EBITDA(千元) | -31,383 | 69,672 | 37,108 | -19,981 | -22,285 | -6,087 | -19,408 | -37,580 | -39,982 | -39,807 |